Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: WGS of matched tumour-normal metastatic prostate adenocarcinoma

PROVIDER: PRJNA608841 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11184928_1.fastq.gz	Fastqsanger.gz
	SRR11184928_2.fastq.gz	Fastqsanger.gz
	SRR11184929_1.fastq.gz	Fastqsanger.gz
	SRR11184929_2.fastq.gz	Fastqsanger.gz
	SRR11184930_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 58

Similar Datasets

CGH microarray analysis of human prostate adenocarcinoma and normal samples

Project description:Prostate adenocarcinoma and matched adjacent normal samples were profiled for copy number with the Agilent 244A CGH Array to support a study of deep transcriptional sequencing on these samples. Two-condition experiment: Prostate adenocarcinoma versus matched normal from three separate patients.

2010-09-23 | E-GEOD-24282 | biostudies-arrayexpress

CGH microarray analysis of human prostate adenocarcinoma and normal samples

2010-09-23 | GSE24282 | GEO

DNA methylation screening of small bowel adenocarcinoma

Project description:Illumina Infinium 450k screening of normal and tumour tissue in a retrospective 28 sample cohort of small bowel adenocarcinoma patients. Average signal and beta values normalised to internal Illumina controls. Comparing DNA methylation differences in a matched normal tumour cohort of 28 small bowel adenocarcinoma patients.

2015-09-03 | E-GEOD-61467 | biostudies-arrayexpress

Deep transcriptional sequencing analysis of human prostate adenocarcinoma and reference samples

Project description:Prostate adenocarcinoma and matched adjacent normal samples were profiled by deep transcriptional sequencing to analyze transcription-induced chimeras and gene fusions. Reference samples from the MAQC and brain and universal reference libraries were also sequenced. Two-condition experiment plus reference samples: Prostate adenocarcinoma versus matched normal from three separate patients, plus brain and universal reference samples from the MAQC project.

2010-09-23 | E-GEOD-24283 | biostudies-arrayexpress

Gene expression profiling of small bowel adenocarcinoma

Project description:The whole genome DASL HT assay was used in combination with the HumanHT-12 v4 BeadChip for screening normal and tumour tissue in a retrospective 28 sample cohort of small bowel adenocarcinoma patients. Non-normalized and average normalized (background subtracted) data Comparing differences in gene expression in a matched normal tumour cohort of 28 small bowel adenocarcinoma patients.

2015-09-03 | E-GEOD-61465 | biostudies-arrayexpress

Colorectal cancer anti-ORF1p LFQ IP-MS

Project description:Here, three colorectal tumors were subjected to anti-ORF1p LFQ, IP-MS: (A) Krukenberg Carcinoma, Ovary; (B) Metastatic Rectal Adenocarcinoma, Liver; (C) Adenocarcinoma, Colon. These were accompanied by matched normal IP controls and/or mouse IgG IP controls. The objective is to map LINE-1 RNP interactions in cancer.

2019-08-23 | PXD013743 | Pride

Integrated multi-omics assessment of lineage plasticity features in a prostate cancer patient with brain and dural metastases

Project description:Metastasis to the brain is rare in prostate cancer and unfortunately, incredibly lethal. We evaluated the tissue biopsies of a patient with a treatment-induced metastatic lesion to the brain of the neuroendocrine prostate cancer (NEPC) subtype. We performed genomic, transcriptomic, and proteomic characterization on the primary prostate tumor, the metastatic brain NEPC, and an additional metastatic nodule in the dura with adenocarcinoma histology. These data are the proteomics result of this patient, with three replicates for each sample (primary prostate, dura adenocarcinoma, brain NEPC).

2024-06-12 | MSV000095007 | MassIVE

Integrated genome and transcriptome sequencing identifies a novel case of hybrid and aggressive prostate cancer

Project description:Next generation sequencing is making sequence-based molecular pathology and personalised oncology viable. We selected an individual initially diagnosed with conventional, but aggressive, prostate adenocarcinoma and sequenced the genome and transcriptome from primary and metastatic tissues collected prior to hormone therapy. The histology-pathology and genomic architecture were remarkably homogeneous, yet it was possible to determine the quadrant of the prostate tumour that likely seeded the metastatic diaspora. Despite a homogenous cell type, our transcriptome analysis revealed signatures of both luminal and neuroendocrine cell types. Remarkably, the repertoire of expressed but private gene fusions, including C15orf21:MYC, recapitulated this biology while the amplification and over expression of the stem cell gene MSI2 may have contributed to the stable hybrid cellular identity. This hybrid luminal-neuroendocrine tumour appears to represent a novel and highly aggressive case of prostate cancer with unique biological features and conceivably a propensity for rapid progression to castrate-resistance. Overall, this work highlights the importance of integrated analyses of genome, exome and transcriptome sequences for basic tumour biology, sequence-based molecular pathology, and personalized oncology.

2011-12-22 | GSE34649 | GEO

Integrated genome and transcriptome sequencing identifies a novel case of hybrid and aggressive prostate cancer

2011-12-22 | E-GEOD-34649 | biostudies-arrayexpress

Project description:a whole genome sequencing (WGS) study of 88 matched HCC tumour/normal pairs

| PRJEB2869 | ENA